AB

Anil Bhayana

Active Director Director DIN 06802780
DIN 06802780 First appointment Jul 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2014
Shareholding value •••• Premium profile

About Anil Bhayana

Data last updated:

Anil Bhayana is a Director at Mercury Meditek Systems Private Limited (since 2014). The company operates in Pharma. Mercury Meditek Systems Private Limited reported revenue of ₹8.07 Cr (FY 2024).

DIN 06802780
Primary Designation Director
Industry Pharma
First Appointment 01 Jul 2014
Oldest Company Age 16 yrs
Largest company Mercury Meditek Systems Private Limited · ₹8.07 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jul 20142010₹8.07 Cr (FY 2024)Active

Board colleagues of Anil Bhayana

Directorship timeline

Open interactive timeline →
Mercury Meditek Systems Private Limited
Premium access

Shareholding and investment profile for Anil Bhayana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Bhayana

Anil Bhayana currently holds 1 directorship: Mercury Meditek Systems Private Limited (Director, since 01 Jul 2014, revenue ₹8.07 Cr (FY 2024)).

Anil Bhayana was first appointed on 01 Jul 2014 as Director at Mercury Meditek Systems Private Limited.

The current boards of Anil Bhayana's companies include Sarita Bhayana (Mercury Meditek Systems Private Limited), Sunil Kumar Bhayana (Mercury Meditek Systems Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available